OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Real-time BOERSE MUENCHEN 04:26:43 2024-06-27 am EDT | ||
| 0.924 EUR | +1.54% |
|
| Current month | -12.50% | ||
| 1 month | -10.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.924 | +1.54% |
| 24-06-26 | 0.91 | -4.51% |
| 24-06-25 | 0.953 | +1.60% |
| 24-06-24 | 0.938 | -7.13% |
| 24-06-21 | 1.01 | -5.87% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 04:26 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG6RCU |
| ISIN | DE000GG6RCU0 |
| Date issued | 2024-04-09 |
| Strike | 52.34 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.137 € |
|---|---|
| Lowest since issue | 0.065 € |
| Spread | 0.01 € |
| Spread % | 1.09% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.5
USD
Average target price
53.19
USD
Spread / Average Target
+25.16%
- Stock Market
- Certificates
- Certificat
